<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00755859</url>
  </required_header>
  <id_info>
    <org_study_id>IgANSTAZA</org_study_id>
    <nct_id>NCT00755859</nct_id>
  </id_info>
  <brief_title>&quot;Steroids and Azathioprine Versus Steroids Alone in IgAN&quot;</brief_title>
  <official_title>Corticosteroids and Azathioprine Versus Corticosteroids Alone in IgA Nephropathy: a Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>A. Manzoni Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>A. Manzoni Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a previous trial the investigators found that the effect of steroids in IgA nephropathy
      diminish over time. The difference in renal survival is striking up till the third year, but
      then remains constant. A six-month course of steroid therapy may be not enough to ensure a
      stable remission. The investigators hypothesized that a more aggressive treatment may obtain
      long-term better results. The investigators conducted a randomised controlled trial to assess
      the utility of low-dose azathioprine added to steroids in adult IgAN patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In 1999, we published a multicenter, randomized, controlled trial, which compared a 6-month
      steroid course with supportive therapy in 86 patients with IgAN. After 5 years of follow-up,
      the risk of a 50% increase in plasma creatinine from baseline was significantly lower in the
      treated patients; proteinuria also decreased. However, the effect of steroids seemed to
      diminish over time. The difference in renal survival was particularly striking up till the
      third year, but then remained constant. We hypothesised that a six-month course of steroid
      therapy is not enough to ensure a stable remission, and a more aggressive treatment may be
      required to obtain long-term better results. At this regard, some studies of combined
      treatment with corticosteroids and azathioprine found that treatment was effective in
      preserving renal function and in reducing proteinuria. However, these studies did not clarify
      whether azathioprine added further benefit to steroids in the long term. We conducted a
      randomised controlled trial to assess the utility of low-dose azathioprine added to steroids
      in adult IgAN patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 1998</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>progression of renal disease, estimated by the time to 50% increase in plasma creatinine from baseline.</measure>
    <time_frame>Every month for the first six months, then six months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>evolution of proteinuria over time</measure>
    <time_frame>every months for the first six months and then every six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>safety</measure>
    <time_frame>every months for the first six months and then every six months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">206</enrollment>
  <condition>IGA Nephropathy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six month steroid course plus azathioprine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>six month steroid course</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>steroids plus azathioprine</intervention_name>
    <description>methylprednisolone 1 g i.v. for three consecutive days at the beginning of months 1, 3 and 5, followed by oral prednisone 0.5 mg/kg every other day plus azathioprine 1.5 mg/kg/day for six months</description>
    <arm_group_label>1</arm_group_label>
    <other_name>solumedrol</other_name>
    <other_name>deltacortene</other_name>
    <other_name>azatioprina</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>steroids</intervention_name>
    <description>methylprednisolone 1 g i.v. for three consecutive days at the beginning of months 1, 3 and 5, followed by oral prednisone 0.5 mg/kg every other day for six months</description>
    <arm_group_label>2</arm_group_label>
    <other_name>solumedrol</other_name>
    <other_name>deltacortene</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  biopsy proven IgA nephropathy

          -  creatinine ≤ 2.0 mg/dl for at least three months

          -  proteinuria ≥ 1.0 g/day for at least three months

        Exclusion Criteria:

          -  treatment with steroids or cytotoxic drugs during the previous three years

          -  contraindications to steroids or azathioprine

          -  Henoch-Schöenlein purpura

          -  diabetes mellitus

          -  severe hypertension (diastolic blood pressure &gt; 120 mmHg)

          -  lupus erythematosus systemicus

          -  malignancies

          -  active peptic-ulcer disease

          -  pregnancy

          -  viral hepatitis or other infections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudio Pozzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>A Manzoni Hospital, Lecco, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Locatelli, MD</last_name>
    <role>Study Chair</role>
    <affiliation>A Manzoni Hospital, Lecco, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simeone Andrulli, MD</last_name>
    <role>Study Director</role>
    <affiliation>A Manzoni Hospital, Lecco, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonello Pani, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital &quot;G. Brotzu&quot;, Cagliari, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paolo Altieri, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital &quot;G. Brotzu&quot;, Cagliari, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gian B Fogazzi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital &quot;Maggiore&quot; IRCCS, Milan, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudio Ponticelli, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital &quot;Maggiore&quot; IRCCS, Milan, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital &quot;Bolognini&quot;</name>
      <address>
        <city>Seriate</city>
        <state>BG</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of Montichiari</name>
      <address>
        <city>Montichiari</city>
        <state>Brescia</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;S.Anna&quot;</name>
      <address>
        <city>Como</city>
        <state>CO</state>
        <zip>22100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;Istituti Ospitalieri&quot;</name>
      <address>
        <city>Cremona</city>
        <state>CR</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;S.Marta e S.Venera&quot;,</name>
      <address>
        <city>Acireale</city>
        <state>CT</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;S.Vincenzo&quot;</name>
      <address>
        <city>Taormina</city>
        <state>CT</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Nephrology and Dialysis, A. Manzoni Hospital</name>
      <address>
        <city>Lecco</city>
        <state>LC</state>
        <zip>23900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;Maggiore&quot;</name>
      <address>
        <city>Lodi</city>
        <state>LO</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;Uboldo&quot;</name>
      <address>
        <city>Cernusco sul Naviglio</city>
        <state>MI</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of Desio</name>
      <address>
        <city>Desio</city>
        <state>MI</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;Maggiore&quot; IRCCS</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;A.Segni&quot;</name>
      <address>
        <city>Ozieri</city>
        <state>Nuoro</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;Spedali Civili&quot;</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;G. Brotzu&quot; Hospital</name>
      <address>
        <city>Cagliari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;Cannizzaro&quot;</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;Careggi&quot;</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of University</name>
      <address>
        <city>Foggia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;C. Poma&quot;</name>
      <address>
        <city>Mantova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;S. Francesco&quot;</name>
      <address>
        <city>Nuoro</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;V. Cervello&quot;</name>
      <address>
        <city>Palermo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Parma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione Maugeri&quot; IRCCS</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CNR-IBIM</name>
      <address>
        <city>Reggio Calabria</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;S. Maria Nuova&quot;</name>
      <address>
        <city>Reggio Emilia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of Sondrio</name>
      <address>
        <city>Sondrio</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CMID</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital &quot;Belcolle&quot;</name>
      <address>
        <city>Viterbo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inselspital</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Locatelli F, Pozzi C, Del Vecchio L, Andrulli S, Pani A, Fogazzi G, Altieri P, Ponticelli C. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial. J Nephrol. 1999 Sep-Oct;12(5):308-11.</citation>
    <PMID>10630693</PMID>
  </reference>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2008</study_first_submitted>
  <study_first_submitted_qc>September 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2008</study_first_posted>
  <last_update_submitted>September 18, 2008</last_update_submitted>
  <last_update_submitted_qc>September 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2008</last_update_posted>
  <responsible_party>
    <name_title>Claudio Pozzi</name_title>
    <organization>A. Manzoni Hospital, Lecco, Italy</organization>
  </responsible_party>
  <keyword>IgA nephropathy</keyword>
  <keyword>steroids</keyword>
  <keyword>azathioprine</keyword>
  <keyword>chronic kidney disease progression</keyword>
  <keyword>proteinuria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Glomerulonephritis, IGA</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
    <mesh_term>Azathioprine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

